Form 4: United Therapeutics Director Judy D. Olian Reports Stock Transactions
SEC Form 4 Filing
Director Judy D. Olian reports the vesting of restricted stock units and subsequent conversion into common stock of United Therapeutics.
Summary
- On July 13, 2024, Judy D. Olian, a director of United Therapeutics Corp, had 1,800 restricted stock units vest and convert into 1,800 shares of common stock.
- The transaction was reported on July 15, 2024.
- Following the transaction, Olian directly owns 7,405 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 07/13/2024 | Restricted stock units vested and converted into common stock. |
| 07/15/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.